Innova Captab Q1 FY27: Revenue up 34% to ₹470.9 Cr, PAT surges 42% to ₹44.1 Cr
Innova Captab reported Q1 FY27 consolidated revenue of ₹470.9 Cr, up 34% YoY. PAT grew 42% to ₹44.1 Cr. CDMO revenue rose 32% to ₹328.7 Cr, and branded generics increased 39% to ₹142.2 Cr. The company reaffirmed its FY27 guidance of over 20% revenue growth.
The significant growth in key financial metrics (revenue, PAT) and reaffirmation of strong future guidance indicate a substantial positive impact on the company's financial standing and investor confidence.
The company reported strong year-on-year growth in revenue, EBITDA, and profit after tax, exceeding analyst expectations and reaffirming positive future guidance.
Innova Captab Limited announced strong financial results for the first quarter of FY27, reporting a consolidated revenue of ₹470.9 crores, marking a significant 34% year-on-year growth. The company's EBITDA for the quarter stood at ₹75.1 crores, a 33% increase year-on-year, with a margin of 16%. Profit after tax (PAT) saw a substantial surge of 42% to ₹44.1 crores.
The CDMO business demonstrated robust performance with revenue of ₹328.7 crores, a 32% year-on-year growth, driven by an expanding product portfolio, new customer acquisitions, and deeper engagement with existing clients. The branded generic business also maintained healthy momentum, recording revenue of ₹142.2 crores, a 39% year-on-year increase, attributed to continued traction in key markets and a broadening product offering.
Exports contributed 32% of the revenue, highlighting the company's expanding international presence. The newly commissioned Jammu facility is ramping up, contributing approximately ₹107 crores in revenue this quarter and achieving positive EBITDA of ₹1 to ₹1.5 crores. Management reiterated confidence in delivering on the FY27 guidance of over 20% revenue growth and profitability outpacing revenue, driven by a diversified business model and disciplined execution.
What to do with a filing like this
Innova Captab Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Innova Captab Limited. Read the original for the full detail.